Key metrics and charts across all fundamental categories.
Stock price and market valuation
NOV trades at $18.68, a 22.7% increase year-over-year. Market capitalization stands at $6.74B, up 16.3% from the prior year. Track NOV price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$8.69B in TTM revenue declined 1.4% YoY, reaching $2.05B last quarter. TTM EBITDA of $747.00M on operating income of $47.00M shows growth is flowing through. Net income of $91.00M TTM confirms the company is converting revenue into profit. Revenue is contracting — assess whether this is cyclical or structural.
Assets, cash, debt, and leverage
With $11.14B in assets and $1.69B in long-term debt, the D/E of 0.3 shows a conservative capital structure — the company has a strong financial cushion to weather downturns.
Price multiples and return ratios
At 74.1x P/E, the stock trades at a premium — the market expects above-average growth. P/S of 0.8x and P/B of 1.1x provide additional context. The premium P/E is not backed by strong revenue growth — the stock may be overvalued.
Operating efficiency and return metrics
Op. margin of 2.3% is down 4.9% YoY — costs are rising relative to revenue. Net margin at 0.9% and gross margin of 18.5%. ROE of 1.5% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $-91.00M on $-26.00M in operating cash flow. The FCF / Net Income ratio of -1.0x shows cash consumption — the business is not yet self-funding. Cash reserves of $1.34B provide financial flexibility. Shares outstanding declined 5.2% YoY — buybacks are returning capital to shareholders.
